Ledger.Open graph →
SEC Form D · filed June 24, 2020

Appili Therapeutics Inc

Offering
$1.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HALIFAX, Nova Scotia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Juergen C. Froehlich · HALIFAX, Nova Scotia, CanadaDirectorIan C. Mortimer · HALIFAX, Nova Scotia, CanadaDirectorBrian M. Bloom · HALIFAX, Nova Scotia, CanadaDirectorKimberly D. Stephens · HALIFAX, Nova Scotia, CanadaExecArmand C. Balboni · HALIFAX, Nova Scotia, CanadaExec · DirectorTheresa C. Matkovits · HALIFAX, Nova Scotia, CanadaDirectorLouis J. Decesare, Jr · Philadelphia, PADirectorPaul D. Rutkowski · Philadelphia, PAExecCharles B. Crawford, Jr · Philadelphia, PADirectorWarren A. Kirshenbaum · Newton, MADirectorJill K. Jinks · Philadelphia, PAExec · DirectorRobert N. Nix, Iii · Philadelphia, PADirectorJoseph P. Bramante · Houston, TXDirectorChristopher Trosper · West Des Moines, IADirectorMichael Quinlivan · London, United KingdomDirectorJoshua Fremed · New York, NYDirectorRobert A. Bettigole · New Haven, CTExecStephen Strittmatter · Durham, CTExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗